Wednesday's session: gap up and gap down stocks
By Mill Chart
Last update: Mar 13, 2024
These stocks are gapping in today's session
Today's gap up stocks
| Ticker | Change | Comment |
|---|---|---|
| HPCO | 1.0K% | HEMPACCO CO INC's (NASDAQ:HPCO) shares surged 1.0K% to $2.6 with a remarkable gap of 589.0%. Shareholders saw the stock price going 23.46% lower in the past month. |
| NCNA | 63.05% | NUCANA PLC-ADR's (NASDAQ:NCNA) shares surged 63.05% to $0.63 with a remarkable gap of 29.77%. Shareholders saw the stock price going 28.2% higher in the past month. |
| HRTX | 28.39% | In today's session, HERON THERAPEUTICS INC's (NASDAQ:HRTX) stock experienced a notable rise of 28.39%, reaching $3.03 with a significant 4.44% gap. Shareholders saw the stock price going 30.39% higher in the past 3 months. |
| KTRA | 27.75% | KINTARA THERAPEUTICS INC's (NASDAQ:KTRA) shares rose 27.75% to $0.11 with a gap of 18.48% during Wednesday's session. In the last month the share price dropped with 29.15%. |
| SKIN | 24.4% | BEAUTY HEALTH CO/THE's (NASDAQ:SKIN) shares soared 24.4% to $4.47 in Wednesday's session, displaying an impressive 14.13% gap. Yesterday the company had a press release: BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results. |
| SOUNW | 22.58% | SOUNDHOUND AI INC's (NASDAQ:SOUNW) shares soared 22.58% to $3.8 during Wednesday's session, accompanied by a significant gap of 5.08%. Shareholders saw the stock price going 1.0K% higher in the past month. |
| CUE | 21.47% | CUE BIOPHARMA INC's (NASDAQ:CUE) shares rose 21.47% to $2.15 with a gap of 2.08% during Wednesday's session. In the last month the stock lost 30.59%. |
| LICY | 20.04% | During Wednesday's session, LI-CYCLE HOLDINGS CORP's (NYSE:LICY) stock price showed a remarkable increase of 20.04%, reaching $0.7 with a notable 8.98% gap. A press release (Li-Cycle Announces $75 Million Strategic Investment from Glencore) was released yesterday. |
| SIGA | 19.39% | Exciting news for SIGA TECHNOLOGIES INC's (NASDAQ:SIGA) stock! It advanced 19.39% to $6.35 in today's session, accompanied by a substantial gap of 4.18%. Yesterday the company had a press release: SIGA Declares Special Cash Dividend of $0.60 Per Share. |
| WSM | 17.64% | Exciting news for WILLIAMS-SONOMA INC's (NYSE:WSM) stock! It advanced 17.64% to $283.58 in today's session, accompanied by a substantial gap of 7.27%. The stock is trading 67.41% higher than 6 months ago. |
Our gap up stocks screener will show you the full list.
Today's top gap down stocks
| Ticker | Change | Comment |
|---|---|---|
| HNRA | -39.6% | In today's session, HNR ACQUISITION CORP's (NYSEARCA:HNRA) stock witnessed a 39.6% fall to $2.7 with a 57.33% gap. Shareholders saw the stock price going 125.0% higher in the past month. |
| EFSH | -38.08% | 1847 HOLDINGS LLC's (NYSEARCA:EFSH) shares fell 38.08% to $1.61 during Wednesday's session with a gap of 40.77%. Shareholders saw the stock price going 25.02% higher in the past 3 months. |
| LUNA | -37.38% | Unfortunate news for LUNA INNOVATIONS INC's (NASDAQ:LUNA) stock! It registered a 37.38% decline to $3.92 in today's session, accompanied by a 42.02% gap. A press release (Investigation of Luna Innovations Incorporated (LUNA) Announced by Holzer & Holzer, LLC) was released earlier today. |
| SOS | -30.28% | SOS LTD's (NYSE:SOS) shares experienced a 30.28% decline to $1.49 during Wednesday's session, accompanied by a 35.09% gap. Shareholders saw the stock price going 43.2% lower in the past month. |
| PIII | -25.39% | P3 HEALTH PARTNERS INC's (NASDAQ:PIII) shares experienced a 25.39% decline to $0.76 during Wednesday's session, accompanied by a 36.15% gap. In the last 6 months the stock lost 50.72%. |
| SURG | -25.29% | During Wednesday's session, SURGEPAYS INC's (NASDAQ:SURG) stock price decreased by 25.29% to $5.22 with a significant 35.85% gap. Yesterday the company had a press release: SurgePays Announces Fourth Quarter and Full Year 2023 Financial Results. |
| DUO | -24.16% | FANGDD NETWORK GROUP LTD-ADR's (NASDAQ:DUO) shares suffered a 24.16% decline to $0.56 during Wednesday's session, accompanied by a 32.2% gap. In the last month the share price increased with 32.26%. |
| NAAS | -22.15% | Today, NAAS TECHNOLOGY INC-ADR's (NASDAQ:NAAS) stock experienced a 22.15% fall to $1.16 with a 25.81% gap. In the last 6 months the stock lost 73.25%. |
| BTOG | -22.04% | BIT ORIGIN LTD's (NASDAQ:BTOG) shares suffered a 22.04% decline to $4.12 during Wednesday's session, accompanied by a 27.22% gap. In the last 6 months the share price increased with 245.0%. |
| CMTL | -19.27% | COMTECH TELECOMMUNICATIONS's (NASDAQ:CMTL) stock price is declining with 19.27% to a price of $4.65 with a gap of 25.35%. A press release (Comtech Appoints John Ratigan as Interim Chief Executive Officer) was released earlier today. |
To see the full list of gap down stocks you can use our gap down stocks screener.
CUE BIOPHARMA INC
NASDAQ:CUE (4/19/2024, 3:30:01 PM)
After market: 1.56 0 (0%)1.56
-0.02 (-1.27%)
CUE News
11 days ago - Cue Biopharma, Inc.Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business HighlightsBOSTON, April 08, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of...
17 days ago - InvestorPlaceCUE Stock Earnings: Cue Biopharma Misses EPS, Beats Revenue for Q4 2023CUE stock results show that Cue Biopharma missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
17 days ago - BusinessInsiderCUE Stock Earnings: Cue Biopharma Misses EPS, Beats Revenue for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cue Biopharma (NASDAQ:CUE) just reported results for the fourth quarter of 2023...
18 days ago - Cue Biopharma, Inc.Cue Biopharma to Host Business Update Call and Webcast2 months ago - Cue Biopharma, Inc.Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers SymposiumBOSTON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of...
2 months ago - Cue Biopharma, Inc.Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference4 months ago - InvestorPlaceCUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q3 2023CUE stock results show that Cue Biopharma beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2023.
4 months ago - BusinessInsiderCUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q3 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cue Biopharma (NASDAQ:CUE) just reported results for the third quarter of 2023....
5 months ago - Cue Biopharma, Inc.Cue Biopharma to Present at the JMP Securities Hematology and Oncology SummitBOSTON, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of T...
